Jorgen Hegbrant
Overview
Explore the profile of Jorgen Hegbrant including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
54
Citations
773
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Schouten A, Fischer F, Blankestijn P, Vernooij R, Hockham C, Strippoli G, et al.
Kidney Int
. 2025 Jan;
PMID: 39848405
High-flux hemodialysis (HD) and high-dose hemodiafiltration (HDF) are established treatments for patients with kidney failure. Since HDF has been associated with improved survival rates compared to HD, we evaluated the...
2.
Vernooij R, Hockham C, Strippoli G, Green S, Hegbrant J, Davenport A, et al.
Lancet
. 2024 Nov;
PMID: 39489903
Background: High-dose haemodiafiltration has been shown, in a randomised clinical trial, to result in a 23% lower risk of mortality for patients with kidney failure when compared with conventional high-flux...
3.
Cromm K, Ngoc Pham L, Jaha H, Fischer K, Liegl G, Schappert A, et al.
Kidney360
. 2024 Oct;
PMID: 39356555
Background: We investigated whether psychosocial determinants self-efficacy and social support are associated with Health-Related Quality of Life in hemodialysis patients enrolled in the CONVINCE trial. Methods: We used baseline data...
4.
Natale P, Green S, Rose M, Bots M, Blankestijn P, Vernooij R, et al.
PLoS One
. 2024 Sep;
19(9):e0309773.
PMID: 39240930
Background: Frequent hemodialysis provided more than three times per week may lower mortality and improve health-related quality of life. Yet, the evidence is inconclusive. We evaluated the benefits and harms...
5.
Liegl G, Fischer F, Canaud B, Woodward M, Barth C, Davenport A, et al.
Qual Life Res
. 2024 Aug;
33(11):2987-3001.
PMID: 39103575
Purpose: We applied a previously established common T-score metric for patient-reported and performance-based physical function (PF), offering the unique opportunity to directly compare measurement type-specific patterns of associations with potential...
6.
Rose M, Fischer F, Liegl G, Strippoli G, Hockham C, Vernooij R, et al.
Kidney Int
. 2024 Aug;
106(5):961-971.
PMID: 39089577
In the CONVINCE trial, the primary analysis demonstrated a survival benefit for patients receiving high-dose hemodiafiltration (HDF) as compared with high-flux hemodialysis (HD). A secondary objective was to evaluate effects...
7.
Cheetham M, Ethier I, Krishnasamy R, Cho Y, Palmer S, Johnson D, et al.
Cochrane Database Syst Rev
. 2024 Apr;
4:CD009535.
PMID: 38588450
Background: Home haemodialysis (HHD) may be associated with important clinical, social or economic benefits. However, few randomised controlled trials (RCTs) have evaluated HHD versus in-centre HD (ICHD). The relative benefits...
8.
Heimburger O, Hegbrant J, Martus G, Wilkie M, De Leon C, Carlsson O, et al.
Clin J Am Soc Nephrol
. 2023 Oct;
19(2):224-232.
PMID: 37902732
Background: Volume overload is common in patients treated with peritoneal dialysis (PD) and is associated with poor clinical outcome. Steady concentration PD is where a continuous glucose infusion maintains the...
9.
Blankestijn P, Vernooij R, Hockham C, Strippoli G, Canaud B, Hegbrant J, et al.
N Engl J Med
. 2023 Jun;
389(8):700-709.
PMID: 37326323
Background: Several studies have suggested that patients with kidney failure may benefit from high-dose hemodiafiltration as compared with standard hemodialysis. However, given the limitations of the various published studies, additional...
10.
Liegl G, Fischer F, Woodward M, Torok M, Strippoli G, Hegbrant J, et al.
J Clin Epidemiol
. 2023 Apr;
159:128-138.
PMID: 37105321
Objectives: To investigate whether a multi-item performance outcome measure, the physical performance test (PPT), can be calibrated to a common scale with patient-reported outcome measures, using the Patient-Reported Outcomes Measurement...